Evidence map›Paper›PMID 41145672›Full record

ArticleLeukemia2026

Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 study.

Atte Nikkilä, Olli Lohi, Jonas Abrahamsson, Laimonas Griskevicius, Helene Hallböök, Ólafur Gísli Jónsson, Bendik Lund, Hanne Vibeke Marquart, Ulrik Overgaard, Katrin Palk and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Atte Nikkilä *Tampere Center for Child Health Research, Tampere University, Tampere, Finland. atte.nikkila@tuni.fi.ORCID http://orcid.org/0000-0003-0292-2386
Olli Lohi *Tampere Center for Child Health Research, Tampere University, Tampere, Finland.ORCID http://orcid.org/0000-0001-9195-0797
Jonas AbrahamssonDepartment of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Laimonas GriskeviciusHematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos and Vilnius University, Vilnius, Lithuania.
Helene HallböökDepartment of Medical Sciences, Uppsala University, Uppsala, Sweden.
Ólafur Gísli JónssonDepartment of Pediatrics, Landspitali University Hospital, Reykjavík, Iceland.
Bendik LundDepartment of Pediatrics, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.
Hanne Vibeke MarquartDepartment of Clinical Immunology, Copenhagen University Hospital (rigshospitalet), Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-9740-6522
Ulrik OvergaardDepartment of Hematology. National Hospital, Copenhagen, Denmark.
Katrin PalkDepartment of Hematology, North Estonia Medical Centre, Tallinn, Estonia.
Kaie PruunsildDepartment of Onco-haematology, Talinn Children's Hospital, Talinn, Estonia.
Petter Quist-PaulsenDepartment of Hematology, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.
Nina ToftDepartment of Hematology, Rigshospitalet University Hospital, Copenhagen, Denmark.
Goda Elizabeta VaitkevicieneCenter for Pediatric Oncology and Hematology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Ulla Wartiovaara-KauttoDepartment of Hematology, Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-2803-2712
Mats HeymanChildhood Cancer Research Unit, Karolinska Institute, Astrid Lindgren's Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-7637-1949
Kim VettenrantaUniversity of Helsinki and Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-8535-0135
Kjeld SchmiegelowInstitute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-0829-4993

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41145672
PMCPMC12789026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.